Abstract
Background The “Body Mass Index” (BMI) or “Quetelet Index” is the most widely used tool to diagnose the degree of obesity. Anyone can calculate it, with no other tools than a scale and a measuring rod. However, its accuracy in predicting body fat percentage is low. The aim of this study is to find an alternative to BMI that is more reliable, accessible and easily applicable in daily clinical practice.
Methods Using the K-means method (an unsupervised classification algorithm), we performed a cluster analysis of the two phase angles obtained with bioimpedance analysis (BIA) of 641 women with different health status. BMI, age, diseases, treatments and any other data other than the phase angle values of the participants were not taken into account.
Results The clusters generated by the K-means algorithm do not coincide with the BMI categories, nor with the predetermined division of individuals into healthy and pathological.
The K-means clustering algorithm identified new patterns that provide information on the greater or lesser predisposition of different individuals to suffer from diseases, taking as a reference their pathological peers in the same cluster.
Conclusions The categories generated by the K-means algorithm based on the phase angles obtained by BIA classify individuals according to their health status independently of other variables such as age or BMI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Dra. Fuentes Medical Nutrition Center gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
fsebio{at}cmpont.es
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam.